关于一个新兴靶点的最新观点：第八届蛋白激酶CK2国际会议精选论文
An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2.
作者信息
Jose Joachim, Le-Borgne Marc, Pinna Lorenzo A, Montenarh Mathias
机构信息
PharmaCampus, Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Corrensstr. 48, 48149 Münster, Germany.
EA 4446 Bioactive Molecules and Medicinal Chemistry, Faculté de Pharmacie-ISPB, Université Lyon 1, Université de Lyon, SFR Santé Lyon-Est CNRS UMS3453-INSERM US7, 69373 Lyon cedex 8, France.
出版信息
Pharmaceuticals (Basel). 2017 Mar 23;10(2):33. doi: 10.3390/ph10020033.
Abstract
n/a.
摘要
无可用信息。
相似文献
1
An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2.关于一个新兴靶点的最新观点：第八届蛋白激酶CK2国际会议精选论文
Pharmaceuticals (Basel). 2017 Mar 23;10(2):33. doi: 10.3390/ph10020033.
2
Papers presented at the 8th international conference of maternity care researchers.在第八届孕产妇护理研究人员国际会议上发表的论文。
J Perinat Educ. 2001 Winter;10(1):41-4. doi: 10.1624/105812401X88048.
3
Introduction to selected papers from the 8th International Conference on Bioinformatics and Computational Biology (BICOB 2016).第八届生物信息学与计算生物学国际会议（BICOB 2016）入选论文介绍
J Bioinform Comput Biol. 2017 Jun;15(3):1702002. doi: 10.1142/S0219720017020024. Epub 2017 Jun 1.
4
CK2-An Emerging Target for Neurological and Psychiatric Disorders.CK2——神经和精神疾病的新兴靶点。
Pharmaceuticals (Basel). 2017 Jan 5;10(1):7. doi: 10.3390/ph10010007.
5
Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies.酪蛋白激酶II（CK2）作为血液系统恶性肿瘤的治疗靶点
Curr Pharm Des. 2017;23(1):95-107. doi: 10.2174/1381612822666161006154311.
6
A historical view of protein kinase CK2.蛋白激酶CK2的历史视角。
Cell Mol Biol Res. 1994;40(5-6):383-90.
7
Select Papers From the 8th Aging and Speech Communication Conference.选自第八届衰老与言语交流会议的论文。
J Speech Lang Hear Res. 2021 Feb 17;64(2):299-301. doi: 10.1044/2021_JSLHR-21-00031. Epub 2021 Feb 9.
8
Emerging roles of protein kinase CK2 in abscisic acid signaling.蛋白激酶CK2在脱落酸信号传导中的新作用。
Front Plant Sci. 2015 Nov 3;6:966. doi: 10.3389/fpls.2015.00966. eCollection 2015.
9
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2.赖氨酸特异性去甲基化酶1是蛋白激酶CK2的一种新型底物。
Biochim Biophys Acta. 2014 Apr;1844(4):722-9. doi: 10.1016/j.bbapap.2014.01.014. Epub 2014 Jan 31.
10
Proceedings of the Sixth International Conference on Protein kinase CK2, September 7-10, 2010, Cologne, Germany.第六届蛋白激酶CK2国际会议论文集，2010年9月7日至10日，德国科隆
Mol Cell Biochem. 2011 Oct;356(1-2):1-275.
引用本文的文献
1
Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7.自组装超分子纳米颗粒提高CK2抑制剂THN7的细胞毒疗效。
Pharmaceuticals (Basel). 2018 Jan 26;11(1):10. doi: 10.3390/ph11010010.
2
2017: A Fruitful Year for Pharmaceuticals.2017年：制药行业硕果累累的一年。
Pharmaceuticals (Basel). 2017 Dec 21;11(1):1. doi: 10.3390/ph11010001.
3
Progress Confirmed for Pharmaceuticals in 2016.2016年制药行业进展得到确认。
Pharmaceuticals (Basel). 2016 Dec 26;10(1):1. doi: 10.3390/ph10010001.
本文引用的文献
1
Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks.蛋白激酶CK2：调节细胞网络中的复杂关系
Pharmaceuticals (Basel). 2017 Mar 5;10(1):27. doi: 10.3390/ph10010027.
2
The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.CK2抑制剂的发展：从传统药理学到计算机辅助合理药物设计
Pharmaceuticals (Basel). 2017 Feb 20;10(1):26. doi: 10.3390/ph10010026.
3
CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.CK2分子靶向——RNA干扰在多种癌症模型中的肿瘤细胞特异性递送
Pharmaceuticals (Basel). 2017 Feb 21;10(1):25. doi: 10.3390/ph10010025.
4
Inhibition of Protein Kinase CK2 Prevents Adipogenic Differentiation of Mesenchymal Stem Cells Like C3H/10T1/2 Cells.抑制蛋白激酶CK2可防止间充质干细胞（如C3H/10T1/2细胞）发生脂肪生成分化。
Pharmaceuticals (Basel). 2017 Feb 9;10(1):22. doi: 10.3390/ph10010022.
5
Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.靶向蛋白激酶CK2：评估CX-4945在免疫健全小鼠中治疗GL261胶质母细胞瘤的潜力。
Pharmaceuticals (Basel). 2017 Feb 12;10(1):24. doi: 10.3390/ph10010024.
6
The Link between Protein Kinase CK2 and Atypical Kinase Rio1.蛋白激酶CK2与非典型激酶Rio1之间的联系
Pharmaceuticals (Basel). 2017 Feb 7;10(1):21. doi: 10.3390/ph10010021.
7
In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface.寻找靶向柔性CK2亚基界面的小分子抑制剂。
Pharmaceuticals (Basel). 2017 Feb 3;10(1):16. doi: 10.3390/ph10010016.
8
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.癌症中的CK2：细胞与生化机制及潜在治疗靶点
Pharmaceuticals (Basel). 2017 Jan 28;10(1):18. doi: 10.3390/ph10010018.
9
Exploring the CK2 Paradox: Restless, Dangerous, Dispensable.探索CK2悖论：永不停歇、危险、可有可无。
Pharmaceuticals (Basel). 2017 Jan 20;10(1):11. doi: 10.3390/ph10010011.
10
Ablation of Protein Kinase CK2β in Skeletal Muscle Fibers Interferes with Their Oxidative Capacity.骨骼肌纤维中蛋白激酶CK2β的缺失会干扰其氧化能力。
Pharmaceuticals (Basel). 2017 Jan 19;10(1):13. doi: 10.3390/ph10010013.
Zotero 插件